References
- Del Pozo E. Management of borderline hyperprolactinemia. Horm Res 1985; 22: 204–8
- Reinthaller A, Deutinger J, Csaicsich P, et al. Effect of serum prolactin on cycle stimulation and fertilization of human oocytes. Geburtshilfe Frauenheilkd 1987; 47: 246–8
- Huang KE, Bonfiglio TA, Muechler EK. Transient hyperprolactinemia in infertile women with luteal phase deficiency. Obstet Gynecol 1991; 78: 651–5
- Pattinson HA, Taylor PJ, Fleetham JA, et al. Transient hyperprolactinemia has no effect on endocrine response and outcome in in-vitro fertilization (IVF). J In Vitro Fert Embryo Transf 1990; 7: 89–93
- Hummel WP, Clark MR, Talbert LM. Transient hyperprolactinemia during cycle stimulation and its influence on oocyte retrieval and fertilization rates. Fertil Steril 1990; 53: 677–81
- Chang SP, Ng HT, Lan TI, et al. Transient hyperprolactinemia in gonadotrophin-stimulated cycles for in vitro fertilization and its effect on conception. Chung Hua I Hsueh Tsa Chin (Taipei) 1993; 51: 401–6
- Kamel MA, Zabel G, Bernard W, et al. Comparison between prolactin, gonadotrophins and steroid hormones in serum and follicular fluid after stimulation with gonadotrophin-releasing hormone agonists and human menopausal gonadotrophin for an in vitro fertilization programme. Hum Reprod 1994; 9: 1803–6
- Jinno M, Yoshimura Y, Ubukata Y, et al. A novel method of ovarian stimulation for in vitro fertilization: bromocriptine-rebound method. Fertil Steril 1996; 66: 271–4
- Jinno M, Katsumata Y, Hoshiai T, et al. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method. J Clin Endocrinol Metab 1997; 82: 3603–11
- Mendoza C, Cremades N, Martinez F, et al. Relationship between fertilization results after intracytoplasmic sperm injection and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod 1999; 14: 628–35